Display Settings:

Format

Send to:

Choose Destination

    J Struct Biol. 2000 Feb;129(1):96-9.

    Crystallization and 1.1-A diffraction of chorismate lyase from Escherichia coli.

    Stover C, Mayhew MP, Holden MJ, Howard A, Gallagher DT.

    NIST Biotechnology Division, Gaithersburg, Maryland 20899-8312, USA.

    Chorismate pathway enzymes are important as producers of nonnucleotide aromatic compounds. The enzyme chorismate lyase from Escherichia coli has been crystallized in four distinct forms, three of which have been characterized by X-ray diffraction. Despite widespread screening, all four crystal forms grow from the same chemical conditions. The wild-type enzyme tends to aggregate, even in the presence of reducing agent, and yielded only one crystal form (monoclinic, form 1) that grew in intricate clusters. Chemical modification of the cysteines mitigated problems with aggregation and solubility but did not affect crystal growth behavior. Protein aggregation was largely eliminated by mutating the protein's two cysteines to serines. The double mutant retains full enzymatic activity and crystallizes in three new forms, one of which (triclinic) diffracts to 1.1-A resolution. Copyright 2000 Academic Press.

    PMID: 10675300 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Click here to read

    Structures reported by this article